Protein Selectivity
Protein Selectivity - Related Videos
05:22
Using Phage Display to Select Proteins with High Affinity to a Target Protein
0 Views •
2025
In this video, we demonstrate the phage display technique to isolate pre-engineered phages expressing proteins with high affinity to the target protein.
09:04
Selected Reaction Monitoring Mass Spectrometry for Absolute Protein Quantification
0 Views •
Cited by 15 •
2015
This protocol describes how to perform absolute quantification assays of target proteins within complex biological samples using selected reaction monitoring. It was used to accurately quantify proteins of the mouse macrophage chemotaxis signaling pathway. Target peptide selection, assay development, and qualitative and quantitative assays are described in detail.
12:36
A Protocol for Phage Display and Affinity Selection Using Recombinant Protein Baits
0 Views •
Cited by 3 •
2014
Phage display is a powerful technique to capture proteins or protein moieties that interact with an immobilized molecule of interest. Once a decision of the type of phage cDNA library to create and screen has been made, the protocol described here permits efficient affinity selection leading to identification of interactors.
10:21
Automated Hydrophobic Interaction Chromatography Column Selection for Use in Protein Purification
0 Views •
Cited by 17 •
2011
An automated method for identifying suitable hydrophobic interaction chromatography (HIC) media to be used in the process of protein purification is presented. The method utilizes a medium-pressure liquid chromatography system including automated buffer blending, dynamic sample loop injection, sequential column selection, multi-wavelength analysis, and split fraction eluate collection.
09:01
Mutagenesis and Functional Selection Protocols for Directed Evolution of Proteins in E. coli
0 Views •
Cited by 12 •
2011
Here we demonstrate a simple protocol to create a random mutant library for a given target sequence. We show how this method, which is performed in vivo in Escherichia coli, can be coupled with functional selections to evolve new enzymatic activities.
FAQs
Shape, charge, flexibility, and the chemical interactions at a binding interface determine how well a molecule fits a protein site. Selectivity can also reflect differences among proteins in their structure, abundance, or cellular location. Considering these variables helps explain why a drug, antibody, or peptide may favor one protein or variant over closely related alternatives.
Strong binding to one protein does not by itself establish selectivity. Selectivity requires comparing that interaction with binding to other proteins or variants and determining whether the preferred interaction is sufficiently stronger or more specific. This distinction matters because a molecule can recognize its intended target yet also interact with other proteins, potentially affecting its usefulness in cancer research.
Cancer-associated protein variants may differ from corresponding healthy-cell proteins in structure, abundance, or cellular location. Those differences can alter molecular recognition and the resulting functional response. Evaluating both the relevant variant and comparable proteins therefore helps determine whether an intervention preferentially affects oncogenic signaling while limiting effects on healthy cells.
Researchers assess selective binding by comparing how a molecule interacts with the intended protein or variant and with other relevant proteins. They then examine functional responses to determine whether stronger recognition produces the expected biological effect. Combining binding measurements with functional results provides a more informative basis for judging selectivity than either type of evidence alone.
Protein selectivity supports target validation by testing whether a molecule preferentially recognizes the protein linked to a cancer-relevant process and whether that recognition changes the expected function. Comparing target and alternative proteins can reveal whether the observed response is target-related. This evidence helps distinguish a promising molecular target from an interaction that lacks sufficient specificity.
Selective recognition can help direct therapeutic action toward oncogenic signaling or a cancer-associated protein variant while reducing interactions with proteins in healthy cells. Researchers can use selective binding and functional-response data to identify responsive biological contexts and support biomarker development. These results contribute to treatment strategies tailored to molecular features of individual cancers.